NASDAQ: KZIAKazia Therapeutics Revenue
Kazia Therapeutics revenue was $1.19M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, KZIA annual revenue was $1.2M, with -27.2% growth year-over-year.
KZIA past revenue growth
How has KZIA's revenue growth performed historically?
Company
-27.25%
Industry
270.86%
Market
22.17%
KZIA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KZIA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KZIA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
KZIA revenue history
Current Revenue
$1.2M
Current Earnings
-$13.6M
Current Profit Margin
-1,131.9%
Be the first to know when KZIA announces revenue.
KZIA Revenue History By Year
| KZIA Yearly Revenue | KZIA Revenue | KZIA Change | KZIA Revenue Growth |
|---|---|---|---|
| 2025-06-30 | $1.20M | -$450.71k | -27.25% |
| 2024-06-30 | $1.65M | $1.65M | +239,958.06% |
| 2023-06-30 | $689.00 | -$16.67k | -96.03% |
| 2022-06-30 | $17.36k | -$11.43M | -99.85% |
| 2021-06-30 | $11.45M | $10.72M | +1,464.64% |
| 2020-06-30 | $731.72k | -$370.39k | -33.61% |
| 2019-06-30 | $1.10M | -$8.61M | -88.65% |
| 2018-06-30 | $9.71M | $2.93M | +43.24% |
| 2017-06-30 | $6.78M | $3.75M | +123.62% |
| 2016-06-30 | $3.03M | $841.75k | +38.44% |
| 2015-06-30 | $2.19M | $1.79M | +442.02% |
| 2014-06-30 | $403.95k | -$1.18M | -74.46% |
| 2013-06-30 | $1.58M | -$846.05k | -34.85% |
| 2012-06-30 | $2.43M | -$61.34k | -2.46% |
| 2011-06-30 | $2.49M | $972.23k | +64.11% |
| 2010-06-30 | $1.52M | -$509.38k | -25.14% |
| 2009-06-30 | $2.03M | -$12.28M | -85.84% |
| 2008-06-30 | $14.31M | -$2.68M | -15.76% |
| 2007-06-30 | $16.98M | $3.44M | +25.42% |
| 2006-06-30 | $13.54M | $86.14k | +0.64% |
| 2005-06-30 | $13.45M | $2.03M | +17.80% |
| 2004-06-30 | $11.42M | -$4.85M | -29.80% |
| 2003-06-30 | $16.27M | $2.58M | +18.89% |
| 2002-06-30 | $13.68M | -$5.37M | -28.17% |
| 2001-06-30 | $19.05M | $3.04M | +18.96% |
| 2000-06-30 | $16.01M | N/A | N/A |
Kazia Therapeutics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.